Company Number: 13760419

Analysis Date: 2025-07-29 18:50 UTC

1. Risk Rating: LOW to MEDIUM
   The company demonstrates positive net assets and growing equity over recent years, with no overdue filings or signs of insolvency. However, the presence of non-current liabilities and limited financial disclosure restricts a full assessment of long-term solvency.

2. Key Concerns:

• Non-current liabilities of £6,803 recorded in 2024 may indicate some longer-term debt obligations that require monitoring.
• Limited financial information due to micro-entity reporting exemptions restricts visibility into profitability and cash flow stability.
• The company has a very small employee base (average 2), which may pose operational risks if key personnel leave or if growth requires scaling.

3. Positive Indicators:

• Increasing net assets and shareholders' funds from £2,310 in 2022 to £10,929 in 2024 indicate improving financial health and capital base.
• Strong liquidity position with net current assets of £16,627 in 2024 and positive working capital.
• No overdue accounts or confirmation statements; compliance with filing deadlines is current.
• Sole director and 100% controller with relevant occupation in the health sector, suggesting aligned management and ownership.

4. Due Diligence Notes:

• Review the nature and terms of the non-current liabilities to understand repayment obligations and interest costs.
• Obtain summary or management accounts if possible to assess profitability, cash flow trends, and revenue sustainability.
• Explore operational dependencies on the sole director and key personnel risks given the small workforce.
• Confirm absence of any contingent liabilities or off-balance-sheet obligations not disclosed in micro-entity accounts.